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Objective: To determine the effect of weight gain on progression of early knee morphologic abnormal-
ities using magnetic resonance imaging (MRI) in a longitudinal study over 48 months.
Design: We studied the right knee of 100 subjects from the Osteoarthritis Initiative (OAI), selecting
subjects aged 45 with osteoarthritis (OA) risk factors who demonstrated weight gain (minimum 5%
increase in body mass index, BMI, n ¼ 50) or no change in weight (BMI change < 2%, n ¼ 50), frequency
matched for age, gender, and baseline BMI. Baseline and 48 month knee MRI studies were scored for
lesions using a modiﬁed whole organ MRI score (WORMS). Logistic regression models were used to
compare the differences between the two groups.
Results: The odds of worsening maximum cartilage (11.3, 95%, CI 3.5e51.4) and meniscal WORMS (4.5,
95% CI 1.4e17.3) were signiﬁcantly greater in the weight gain group compared to the no change group, in
addition to the odds of worsening cartilage defects at the patella and average meniscal WORMS
(P < 0.05). Odds of worsening average bone marrow edema pattern (BMEP) were signiﬁcantly greater for
the weight gain group compared to the no change cohort (P < 0.05).
Conclusion: Our study demonstrated that weight gain is strongly associated with increased progression
of cartilage degeneration in middle-aged individuals with risk factors for OA.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is the most common disease of joints and a
leading cause of disability in the United States, affecting more than
27 million adults and over 35% of the population over the age of
651,2. The associated health care expenditures are enormous with
costs of over $185 billion dollars annually and the incidence is
rising, particularly as a function of both the aging population and
the obesity epidemic3,4. First-line therapy for OA focuses on slow-
ing disease progression and controlling symptoms with a combi-
nation approach that may include exercise, weight loss, physicaljoca.2014.12.025.
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ternational. Published by Elsevier Ltherapy, nonsteroidal anti-inﬂammatory drugs, and/or intra-
articular corticosteroid injections5. For many patients, however,
total joint arthroplasty is eventually required despite faithful
adherence to more conservative measures. The importance of
prevention and disease modiﬁcation is paramount.
Obesity is one of the main risk factors for OA. Previous studies
have shown that there is a 60% lifetime risk of developing symp-
tomatic knee OA in obese patients compared with 45% in the
general population6. Excessive weight gain exacerbates joint
degeneration by increasing joint loading, altering normal kinetics,
and impairing regulatory pathways that maintain cartilage ho-
meostasis4,7. Weight loss is an attractive, cost-effective measure to
potentially slow and prevent the development of OA, but the pre-
cise relationship between weight loss and the pathophysiology of
OA has not beenwell-established. Similarly, only a few studies have
explored the speciﬁc detrimental effects of weight gain in terms of
progression of irreversible morphologic abnormalities, particularly
in articular cartilage7e9. Teichtahl et al., for example, demonstratedtd. All rights reserved.
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weight gainwas associated with 0.2% increased loss of medial tibial
cartilage volume, over the course of 2 years.
The diagnosis and clinical follow-up of patients with OA relies
heavily on imaging with conventional radiography, which utilizes
joint space as a surrogate for hyaline cartilage degeneration in the
early stages of the disease10,11. However, magnetic resonance im-
aging (MRI) has been shown in recent years to be more sensitive to
subtle morphologic abnormalities within joints, and can provide
direct high-resolution imaging of cartilage, meniscus, bonemarrow
and ligament degeneration, which represent the earliest structural
changes in patients with OA12e16.
The Osteoarthritis Initiative (OAI) is a multicenter, longitudinal,
prospective observational study of knee OA, sponsored by the Na-
tional Institutes of Health that combines clinical, serologic, and
joint imaging data obtained annually from 4796 individuals be-
tween 45 and 79 years of age over a period of 8 years (online at
http://www.oai.ucsf.edu). The purpose of this study was to
examine the effect of weight gain on the progression of knee
morphologic abnormalities in asymptomatic individuals aged 45
and older, with risk factors for OA, using serial 3T MRI performed
over a period of 48months as part of the OAI. We hypothesized that
knees of individuals who gained weight would be more likely to
have worsening of focal knee morphological abnormalities,
particularly cartilage degradation, compared to those who did not
gain weight.
Methods
Subjects
The study protocol, amendments, and informed consent docu-
mentation were approved by local institutional review boards. The
study was compliant with the Health Insurance Portability and
Accountability Act and all subjects provided informed consent.
Data used in the preparation of this manuscript was obtained
from the publically available OAI database (http://www.oai.ucsf.
edu/). The study population of the OAI includes subjects with
symptomatic knee OA at baseline (progression cohort), those with
no symptomatic knee OA but with risk factors for OA at baseline
(incidence cohort), and normal controls. The speciﬁc OAI datasets
used for this study were the baseline clinical dataset 0.2.2, baseline
imaging datasets 0.E.1 and 0.C.2, the 48 month follow-up clinical
dataset 6.2.1, and the 48 month follow-up imaging datasets 6.E.1.
We studied the right knee of 100 subjects from the OAI inci-
dence cohort. The OAI performed scans of both knees in the sub-
jects studied but time constraints prevented performing the full
complement of sequences for both knees. A full complement was
not obtained for the left knee. Right knees demonstrate a higher
frequency of radiologic manifestations of OA compared to left
knees17. The right knee was chosen because the full imaging com-
plement was available. Subjects in the OAI incidence cohort
(n ¼ 3284) did not have symptomatic knee OA (deﬁned as frequent
symptoms and radiographic OA in the same knee) in either knee at
baseline, but had at least one of the following OA risk factors at
baseline: overweight or obesity, knee symptoms (“pain, aching, or
stiffness in or around the knee” in the past 12 months), history of
knee injury, history of knee surgery, family history of total knee
replacement or Heberden nodes. Speciﬁc inclusion criteria for the
present study included individuals with either a minimum 5% in-
crease in body mass index (BMI) or less than 2% change in BMI over
48 months. Since there was minimal change in height over 48
months, changes in BMI represented changes in weight. We chose
5% as the minimum threshold for weight gain because recent
studies have demonstrated that this amount of weight gain wasassociated with adverse effects on knee symptoms18. We hypoth-
esized that early morphologic abnormalities seen onMRmight also
be seenwith a 5% increase in weight. The 2% restrictionwas chosen
for the no change group in order to be as restrictive as possible
while establishing a cohort of subjects who met inclusion criteria
and which was relatively comparable in size to those that met the
weight gain inclusion criteria. There were 520 and 808 individuals
in the incidence cohort who met the respective weight change
criteria. Speciﬁc exclusion criteria included individuals with ﬂuc-
tuations in BMI over the 4 year period, i.e., individuals who did not
consistently increase or maintain BMI over the 4 years. For
example, for individuals with >5% weight gain between 0 and 48
months if there was a net weight loss between 0 and 12, 12 and 24,
24 and 36, or 36 and 48months, theywere excluded from the study.
Similarly, for individuals with less than 2% change inweight over 48
months, if therewas >2% change inweight during annual follow-up
intervals, those individuals were excluded. The two groups were
denotedweight gain (WG) and no change (NC). A random sample of
50 individuals with 5% increase in BMI and available physical active
score for the elderly (PASE) scores was selected to compose the
weight gain (WG) group. A sample of 50 individuals each with less
than 2% change in BMI was selected and frequency matched to the
WG group for age, gender, and baseline BMI.
KellgreneLawrence (KL) scores from knee radiographs at base-
line were obtained from the OAI database for all subjects in our
study and included in our analyses. Similarly, since physical activity
may also be an independent risk factor for development of focal
knee abnormalities we used data derived from the PASE in our
analyses. Subjects who did not have a minimum of four of ﬁve
possible reported yearly PASE scores (baseline, 12 months, 24
months, 36 months, 48 months) were excluded.Imaging
MR images for all subjects were obtained using four identical
3.0 T (Siemens MAGNETOM Trio, Erlangen, Germany) scanners and
quadrature transmit-receive coils (USA Instruments, Aurora, OH,
USA) at four sites (The Ohio State University, Columbus, OH; Uni-
versity of Maryland, School of Medicine, Baltimore, MD; University
of Pittsburgh, Pittsburgh, PA; and Memorial Hospital of Rhode Is-
land, Pawtucket, RI). The following sequences were acquired and
used for image analysis: sagittal 3D dual-echo in steady state
(DESS) sequence (TR/TE ¼ 16.3/4.7 ms, spatial resolution ¼
0.365 mm  0.456 mm, slice thickness ¼ 0.7 mm, ﬂip angle 25,
bandwidth 185 Hz/pixel), sagittal 2D intermediate-weighted (IW)
fast spin-echo (FSE) sequence with fat saturation (TR/TE ¼ 3200/
30 ms, spatial resolution ¼ 0.357 mm  0.511 mm, slice
thickness ¼ 3.0 mm, ﬂip angle 180, bandwidth 248 Hz/pixel),
coronal 3D fast low angle shot (FLASH) sequence with selective
water excitation (WE, TR/TE ¼ 20/7.57 ms, spatial
resolution ¼ 0.313 mm  0.313 mm, slice thickness ¼ 1.5 mm), and
coronal 2D IW FSE sequence (TR/TE ¼ 3700/29 ms, spatial
resolution ¼ 0.365 mm  0.456 mm, slice thickness ¼ 3.0 mm, ﬂip
angle 12, bandwidth 352 Hz/pixel). Detailed information about the
sequences is available in the OAI MR protocol19.Image analysis
Baseline and 48 month follow-up MR images of the right knee
were transferred to a picture archiving communication system
(PACS) workstations (Agfa, Ridgeﬁeld Park, NJ, USA). Baseline and
follow-up images were reviewed side-by-side. Using the sequences
listed above, the presence and grade of meniscal, cartilage and
ligamentous lesions as well as bone marrow edema pattern (BMEP)
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as previously described and presented in more detail below14.
A randomized list of IDs for subjects meeting inclusion criteria
were submitted by OAI staff to the study authors. Two radiologists
at the local OAI site (MB with 5 years, LN with 6 years in muscu-
loskeletal imaging, respectively) then analyzed the MRI studies
independently. In any cases where the modiﬁed WORMS gradings
were not identical, a consensus reading was performed with a
third, more experienced radiologist (TML, 23 years of experience in
musculoskeletal imaging). The radiologists were blinded to patient
information while performing the WORMS grading.
WORMS grading of the knee
Meniscal morphology was assessed in six regions: the anterior,
body, and posterior regions of the medial and lateral sides. “Intra-
substance abnormality” was added to the original WORMS classi-
ﬁcation to enable assessment of early degenerative disease. The
grading scale ranged from 0 to 4: 0 ¼ normal, 1 ¼ intrasubstance
abnormalities, 2 ¼ non-displaced tear, 3 ¼ displaced or complex
tear, and 4¼ complete destruction andmaceration of themeniscus.
Cartilage lesions were scored on an eight-point scale:
0 ¼ normal cartilage, 1 ¼ normal thickness but increased or
otherwise abnormal signal on ﬂuid sensitive sequences;
2 ¼ partial-thickness focal defect <1 cm in greatest width;
2.5 ¼ full-thickness focal defect <1 cm in greatest width;
3 ¼ multiple areas of partial-thickness defects intermixed with
areas of normal thickness, or a partial-thickness defect wider than
1 cm but <75% of the region; 4 ¼ diffuse (75% of the region)
partial-thickness loss; 5 ¼ multiple areas of full-thickness loss or a
full-thickness defect wider than 1 cm but <75% of the region;
6 ¼ diffuse (75% of the region) full-thickness loss. For clarity, a
cartilage lesion was deﬁned as any cartilage abnormality, WORMS
grade 1 or higher and a cartilage defect was deﬁned as any cartilage
abnormality, WORMS grade 2 or higher. BMEP was deﬁned as
poorly marginated areas of increased T2 signal intensity graded
using a modiﬁed 4-point WORMS scale: 0, none; 1, diameter
0e5 mm; 2, 5e20 mm; 3, >20 mm.
Cartilage pathology and presence of BMEP was assessed using a
modiﬁed WORMS in which the number of anatomical compart-
ments was reduced from 15 to 6: patella, trochlea, medial femoral
condyle, medial tibia, lateral femoral condyle and lateral tibia (P, T,
MFC, MT, LFC, LT) as previously described14,20,21. This modiﬁed
WORMSwas developed tomore efﬁciently grade lesions in subjects
with relatively mild pathology, which is expected in individuals
without symptomatic OA. The reduction in anatomical compart-
ments can potentially affect the number of grade 4 and grade 6
lesions, which were, however, expected to be rare in the OAI inci-
dence cohort14,20,22,23.
For each subject, compartmental average and overall maximum
WORMS were calculated. Average WORMS was obtained at base-
line and 48 month follow-up for cartilage compartments, menisci,
and BMEP, along with the interval change. Similarly, the WORMS
maximum score (WORMS max) was assigned to each knee at
baseline and 48 month follow-up deﬁned by the greatest WORMS
score in any compartment for cartilage, menisci, and BMEP, as a
measure of the global severity of knee lesions. The change in each
respectiveWORMSmaximum between baseline and follow-up was
also calculated.
Statistical analysis
The statistical analyses were performed with JMP software
version 9-(SAS Institute, Cary, NC, USA) using a two-sided 0.05 level
of signiﬁcance. Descriptive statistics (i.e., mean age, BMI etc.) werecalculated for each group; t-tests and Fisher's exact tests were used
to determine the differences between the subjects in the two
groups at baseline.
The two groups were then compared with respect to increase
over time (yes/no) in the primary outcomes of maximum cartilage,
meniscus, and BMEP WORMS score using logistic regression
models to calculate odds ratios and conﬁdence intervals. These
outcomes were chosen in order to increase sensitivity to global
structural changes. Additional sensitivity analysis was conducted
with respect to the cartilage and meniscus primary analyses to
determine if there was any signiﬁcant difference in the results
when the interval development of signal abnormality (WORMS
grade 1) was excluded from the regression models. Further
exploratory analyses for hypothesis forming included comparisons
of increase over time (yes/no) of individual cartilage compartment
WORMS, average meniscal WORMS, and average BMEP worms
using logistic regression models. Because there were no signiﬁcant
differences in any of the risk factors for OA incidence and pro-
gression, adjustments were only made for baseline BMI, average 5-
year PASE score, and three-level KL score (0e1, 2 or 3e4). When age
or gender were tested as additional covariates, there was no sig-
niﬁcant change in the odds ratios (<10%) compared to the BMI,
PASE, and KL model and therefore, to maintain statistical power,
age and gender were not included as covariates. Similarly, splitting
the KL groups did not signiﬁcantly change the odds ratios and so
they were grouped as 0e1, 2, or 3e4.
To assess the intra- and inter-reader reproducibility of the
WORMS grading, 30 subjects were randomly selected and WORMS
grading was performed by two readers (MB and LN) independently.
Intra-class correlation coefﬁcients were calculated to compare the
exact WORMS score for meniscal and cartilage lesions in each
compartment. The intra-class correlation coefﬁcients for intra-
observer agreement were 0.87 (0.804e0.932) for meniscus
WORMS and 0.86 (0.801e0.928) for cartilage WORMS. Intra-class
correlation coefﬁcients for inter-observer agreement were 0.84
(0.771e0.911) for meniscus WORMS and 0.79 (0.72e0.868) for
cartilage WORMS. These analyses demonstrate good WORMS
grading reproducibility. The intra- and inter-reader reproducibility
ofWORMS grading by our group has also been validated inmultiple
prior studies20,22,24e26.
Results
Baseline subject characteristics and focal knee lesions
Baseline characteristics of all subjects are described in Table I.
There were no signiﬁcant differences in age, baseline BMI, gender,
or any of the selected OA risk factors between the two groups.
Table I also outlines the severity of morphological knee abnor-
malities across the two groups at baseline. At baseline, therewas no
signiﬁcant difference in WORMS severity for baseline cartilage,
meniscus, and BMEP lesions between the two groups (P > 0.05).
Follow-up subject characteristics
Individuals in the NC group and WG group on average had a
weight gain of 0.04% ± 0.95% (range 1.49% to 1.87%) and
15.2% ± 7.8% (range 5.98% to 40.08%), respectively. In theWG group,
women gained slightly more weight on average than men
(16.2% ± 7.3% compared to 13.2% ± 8.6%).
Longitudinal analysis
Figure 1(A) charts the average increase in maximumWORMS in
any cartilage, meniscus, or BMEP compartment. Figure 1(B) charts
Fig. 1. Longitudinal Analysis (A) Average increase in maximum single compartment WORM
indicates signiﬁcant differences after logistic regression analysis (P < 0.05). (B) Average incr
compartments (averaged) and all BMEP compartments (averaged). * indicates signiﬁcant d
Table I
Baseline demographics and WORMS scores of individuals with OA risk factors and
either no change in weight or weight gain over 4 years
No change Weight gain P-value
(n ¼ 50) (n ¼ 50)
Baseline demographics/History
Age [years] ± SD 59.1 ± 8.0 58.0 ± 8.3 0.75
BMI [kg/m2] ± SD 28.7 ± 4.8 28.1 ± 5.3 0.73
Females 33 (72%) 34 (66%) 1.00
Knee symptoms in the past 12 months 47 (94%) 43 (86%) 0.32
History of knee injury 21 (43%) 23 (47%) 0.84
History of knee surgery 11 (22%) 10 (20%) 1.00
Family history of knee replacement
surgery
7 (15%) 10 (20%) 0.60
Heberden nodes 13 (26%) 18 (37%) 0.28
Average 5-year PASE score 169 ± 75 175 ± 78 0.35
KellgreneLawrence score (0e1) 29 (58%) 25 (50%) 0.55
KellgreneLawrence score (2) 13 (26%) 16 (32%) 0.66
KellgreneLawrence score (3e4) 8 (16%) 9 (18%) 1.00
Baseline Cartilage e Mean WORMS ± SD 1.1 ± 1.7 1.6 ± 1.8 0.16
Baseline Meniscus e Mean WORMS ± SD 0.5 ± 1.1 0.7 ± 1.2 0.69
Baseline BMEP e Mean WORMS ± SD 0.4 ± 0.8 0.5 ± 0.9 0.54
*Results are given as a percentage ormean ± standard deviation. A Fisher's exact test
was used for categorical variables and a t-test for continuous variables.
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month follow-up in the six compartments of the knee, in addition
to the average progression in any single meniscal compartment and
any single BMEP compartment, for the two groups. In the WG
group, 34% (17/50) had the worsening of the WORMS score for
menisci, 66% (33/50) for cartilage, and 52% (26/50) for BMEP. By
comparison, in the NC group, 14% (7/50) had worsening of the
WORMS for menisci, 14% (7/50) for cartilage, and 24% (12/50) for
BMEP.
Table II summarizes the odds ratios and conﬁdence intervals for
the comparisons of cartilage, meniscal, and BMEP progression be-
tween the two groups.
With regard to the primary outcomes of increased maximum
cartilage, meniscus, and BMEP WORMS, after controlling for base-
line BMI, average 5-year PASE score, and KL score, there was
signiﬁcantly increased odds of progression of cartilage WORMS
max (OR: 11.3, 95% CI 3.5e51.4, P < 0.001) and meniscus WORMS
max (OR: 4.5, 95% CI 1.4e17.3, P¼ 0.016) in theWG group compared
to the NC group. However, there were no signiﬁcant differences in
change in maximum BMEP between the two cohorts. SensitivityS across all cartilage, meniscal, and BMEP compartments (þone standard deviation). *
ease in WORMS (þone standard deviation) in each cartilage compartment, all meniscal
ifferences after logistic regression analysis (P < 0.05).
Table II
Odds ratios of progression of primary and exploratory analyses
Change in WORMS Weight gain: No change P-value
Cartilage max 11.3 (3.5e51.4)* <0.001
Meniscus max 4.5 (1.4e17.3) 0.016
BMEP max 2.1 (0.7e6.3) 0.174
Cartilage P 8.9 (2.2e60.0) 0.006
Cartilage T ** 0.996
Cartilage MFC 2.9 (0.8e12.1) 0.110
Cartilage LFC 3.8 (1.1e18.2) 0.057
Cartilage MT 3.9 (0.8e28.5) 0.112
Cartilage LT 2.9 (0.8e14.4) 0.134
Meniscal Avg. 3.2 (1.2e9.3) 0.023
BMEP Avg. 3.2 (1.2e9.3) 0.015
*95% conﬁdence intervals are in parentheses. Signiﬁcant results (P< 0.05) are bolded.
**Average increase in trochlear cartilage WORMS in the No Change group was equal
to zero.
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results (odds ratios, conﬁdence intervals, and P-values) when the
interval development of signal abnormality (WORMS grade 1) was
excluded from the regression models. Only four total meniscal
compartments in four individuals and six total cartilage compart-
ments in six individuals demonstrated worsening as deﬁned by
development of signal abnormality.
Regarding the exploratory analyses, there were increased odds
of progression at the patellar cartilage (OR: 8.9, 95% CI 2.2e60.0,
P ¼ 0.006) in the WG group compared to the NC group (Fig. 2).
Additionally, the change inmeniscalWORMS average paralleled the
WORMS max result and also showed a signiﬁcant difference
(P ¼ 0.023). Finally, there were signiﬁcantly elevated odds of
worsening BMEP average in the WG group (OR: 3.2, 95% CI 1.2e9.3,
P ¼ 0.015). The WG group demonstrated a higher average increase
in WORMSmax across any compartment for cartilage, menisci, and
BMEP. This cohort also demonstrated a higher increase in average
cartilage WORMS across each individual cartilage compartment, in
addition to the average meniscal and BMEP compartments.
Discussion
We found that individuals with at least a ﬁve percent weight
gain over 4 years had signiﬁcantly higher progression of cartilage
(global and compartment speciﬁc) and meniscal lesions comparedFig. 2. Sagittal 3D dual-echo in steady state (DESS) sequence images of the right knee at ba
(approximately 5.7% increase in BMI from 33.1 to 35) over 48 months. There is interval deve
and adjacent increased BMEP (WORMS grade 2) (white arrow).to the control cohort with stable weight (less than two percent
change). BMEP average was also signiﬁcantly increased in the
weight gain group compared to the no change group. Our study is
the ﬁrst to speciﬁcally correlate the progression of morphological
abnormalities on knee MRI with at least 4 year change in weight.
While intuitively the link between obesity and OA27e30 would
also suggest an association with weight gain, there have been few
studies examining this possible relationship31. Of note, Manninen
et al. demonstrated that the shift from normal to overweight be-
tween the ages of 20 and 30, 40, or 50 years, carried a higher risk for
knee OA requiring arthroplasty than did persistent increased BMI8.
More recently, Teichtahl et al. showed that weight gain was asso-
ciated with increased cartilage loss in adults with meniscal tears7.
Our study similarly found that even after controlling for baseline
BMI, physical activity, and KL score, patients with weight gain had
signiﬁcantly increased odds of progression of cartilage WORMS
max, meniscal WORMS max, cartilage WORMS at the patella (and
nearly signiﬁcant at the lateral femoral condyle), average meniscal
WORMS, and average BMEP, compared to individuals with no
change in weight. Changes in dynamic joint loading are most likely
pivotal. Basic science and clinical studies have demonstrated that
abnormal loads can alter the composition and physical properties
of articular cartilage32,33. One recent study in particular noted that
dynamic mechanical loading was associated with cartilage defects,
suggesting that increased loading in the setting of weight gain plays
a role in the pathological changes in articular cartilage34. Excessive
weight gain also appears to impair regulatory pathways that
maintain cartilage homeostasis and increase the production of pro-
inﬂammatory adipocytokines, which contribute to cartilage
degeneration35. Additional serological and biochemical studies,
however, are needed in order to precisely characterize how weight
change affects these non-mechanical mechanisms of cartilage loss.
It is unclear why increased odds of cartilage degeneration in our
weight gain group would not be seen in the medial, lateral, or
patellofemoral compartments in a uniform fashion. Joint mala-
lignment might play some role in this phenomenon. Felson et al.,
for example, have previously shown that the association of cartilage
lesions with elevated BMI appears limited to regions of moderate
malalignment36. However, others have shown that cartilage loss is
one of the major drivers of malalignment, further complicating the
issue37e39.seline (A) and 48-month follow-up (B) in a representative individual with weight gain
lopment of a full-thickness focal cartilage defect at the patella >1 cm (WORMS grade 5)
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sample of 50 individuals in each of our groups compared to the
total OAI incidence cohort size. The individuals were not random-
ized to weight gain vs no change in weight and comorbidities not
incorporated into our model might have contributed to changes in
patient weight. Additionally, we controlled for PASE values as part
of our logistic regression analyses, which are limited by the sub-
jective recall of the individuals in our study. Also of note, WORMS
has limited sensitivity for subtle progression of lesions; for
example, there were several patients in our cohorts who showed
subtle increased cartilage defect size, but who did not have a
change in WORMS score. Finally, because of relatively low rates of
progression, we had relatively large 95% CIs, which limits the
informative value of the speciﬁc calculated odds. Thus, the direc-
tion of the statistically signiﬁcant odds ratios is likely more clini-
cally meaningful than the speciﬁc number and associated
conﬁdence intervals reported.
In summary, our study demonstrated that weight gain was
associated with increased progression of early degenerative
changes of cartilage in middle-aged individuals with risk factors for
OA but without initial clinical evidence of the disease. Given the
enormous personal and societal burdens of OA, our ﬁndings
emphasize the importance of public health initiatives aimed not
only toward preventing obesity in overweight individuals, but also
toward maintaining healthy normal weight.
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